Robert F. Kennedy Jr. has allegedly been placed in charge of the public health system in the United States [1, 2, 3].
The claim suggests a fundamental shift in how the U.S. manages national health policy, moving leadership toward a figure known for questioning established medical protocols.
Reports appearing in July 2026 indicate that former President Donald Trump made the decision to appoint Kennedy [1, 2]. These reports, primarily found in editorial sections and online video content, describe the move as a decision to put an extremist in charge of the system [1, 2].
An editorial in the San Diego Union-Tribune said the appointment was a "perverse decision to put an extremist who doesn't believe in the efficacy of public health measures in charge of U.S. public health" [1]. The Orlando Sentinel published a similar critique later this month, echoing the sentiment that the appointment rejects standard public-health measures [2].
Kennedy has long been a critic of vaccine efficacy and traditional public-health mandates. The lack of a formal government announcement or corroboration from major news agencies has left the exact nature of his role unclear. Despite the absence of official confirmation, the reports have sparked debate over the potential impact on national health strategies, specifically regarding immunization and disease prevention.
Critics said that the appointment could jeopardize public safety by undermining scientific consensus. The reports suggest that this shift is driven by the belief that the current public health system requires a radical overhaul, though the specific goals of such a change remain undefined in the available texts [1, 2].
“Donald Trump's perverse decision to put an extremist... in charge of U.S. public health”
The absence of official government confirmation suggests these reports may be based on speculation or limited-scope appointments rather than a formal cabinet-level change. However, the circulation of these claims in regional editorials reflects a high level of anxiety regarding the intersection of political appointments and scientific governance in the U.S. health sector.
